Emerging research suggests that common diabetes medications like metformin and newer GLP-1 therapies may influence biological ageing pathways, sparking renewed interest and cautious optimism in extending healthspan for older adults.
Metformin, a mainstay of type 2 diabetes care for decades, has re-entered the longevity debate as researchers examine whether it might do more than lower blood sugar. A review on PubMed Central says the drug appears to influence several biological pathways linked with ageing, including inflammation, oxidative stress and cellular repair, which has kept it on the edge of anti-ageing discussion even though it is not approved for that use.
The newer excitement, however, increasingly centres on GLP-1 drugs such as semaglutide and tirzepatide. Healthline reports that early studies have linked these medicines with lower inflammation markers and possible effects on cellular ageing, while also raising the possibility of broader metabolic benefits beyond weight loss. That said, the same reporting makes clear that these drugs are prescribed for diabetes and obesity, not longevity.
For older adults, the potential appeal is practical rather than speculative. Healthline notes that GLP-1 medicines may reduce the risk of major cardiovascular events and kidney failure, and can produce substantial weight loss in some patients over 65. Drugs.com adds that metformin and GLP-1 medicines are often used together in diabetes because they work in complementary ways, with GLP-1 drugs often considered earlier when weight loss and stronger glucose control are priorities.
Still, the enthusiasm comes with a reminder that individual reactions vary. The lead article described one reader who reported severe and lasting side effects from metformin and a GLP-1 drug, while the writer said a trial of semaglutide and tirzepatide increased resting heart rate and reduced heart rate variability before returning to baseline after stopping. Those experiences do not overturn the broader safety profile, but they do underscore why any use of these drugs outside their approved purposes remains a decision best made with medical supervision.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
